Jane Street
RDY icon

Jane Street’s Dr. Reddy's Laboratories RDY Stock Holding History

Jane Street’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-30,000
Closed -$391K – 10693
2021
Q3 		$391K Buy
+30,000
New +$400K ﹤0.01% 7715

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Jane Street's RDY Position: Q2 2026 in Review

Jane Street opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 276,875 shares worth $4.01M. The stake represents ﹤0.01% of the portfolio and ranks #4035 among its holdings. This is a return to the name: Jane Street previously reported a position in RDY as recently as Q4 2025.

Jane Street first reported a position in RDY in Q2 2013 and has held it in 37 quarters since. The position peaked at $24.5M in Q4 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Jane Street held 276,875 shares of Dr. Reddy's Laboratories worth $4.01M as of Q2 2026.
  • Dr. Reddy's Laboratories was a new Jane Street position in Q2 2026.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4035 holding.
  • Jane Street first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 37 quarters since.
  • Jane Street's Dr. Reddy's Laboratories position peaked at $24.5M in Q4 2024.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.